Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;19(4):575-82.
doi: 10.1007/s00586-009-1216-1. Epub 2009 Nov 24.

Pyogenic vertebral osteomyelitis: identification of microorganism and laboratory markers used to predict clinical outcome

Affiliations

Pyogenic vertebral osteomyelitis: identification of microorganism and laboratory markers used to predict clinical outcome

Sang Hoon Yoon et al. Eur Spine J. 2010 Apr.

Abstract

The aim of this study is to determine the predictive values of laboratory indicators of pyogenic vertebral osteomyelitis (PVO) and a potential cure if the microorganism cannot be identified. Forty-five consecutive patients with PVO were enrolled. Antibiotic therapy with or without surgery was performed according to microorganism. In the negative-culture (NC) group, cefazolin was administered in cases of hematogenous PVO, and vancomycin was administered in cases of postoperative or procedure-related PVO. The clinical, laboratory, and radiological findings were followed up with regard to an appropriate response to antimicrobial therapy. Nine patients were treated with antibiotics alone. We were able to identify the microorganism in 34 cases (75.6%). Ten cases in NC group were cured without recurrence, but one was not. Identification of the microorganisms did not have any significant influence on the treatment outcome, duration of antibiotic administration or normalization of laboratory profiles. For erythrocyte sedimentation rate (ESR) values over 55 mm/h and C-reactive protein (CRP) values of 2.75 mg/dL at fourth week after antibiotic administration by means of ROC curve analysis, we expect significantly high rates of treatment failure by Pearson chi(2) test (chi(2) = 4.344, Odds ratio = 5.15, p = 0.037, 95% CI 1.004-26.597). Even in patients with negative culture findings, it is expected that a good outcome will be achieved by the administration of cefazolin or vancomycin for about 6 weeks. It is concluded that antibiotics selected according to the etiological setting can be initiated without the need to start empirical antibiotics. In every instance at fourth week after the initiation of antibiotic therapy, the values of CRP and ESR can provide meaningful information regarding whether clinicians need to reevaluate the effectiveness of antibiotics by performing follow-up imaging studies and monitoring the patient's clinical manifestations.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The flow chart of the initial conditions of patients with pyogenic vertebral osteomyelitis (PVO)
Fig. 2
Fig. 2
Comparison of laboratory markers; a white blood cell (WBC) count, b erythrocyte sedimentation rate (ESR) and c C-reactive protein (CRP) between the positive culture group and negative culture group. Both sensitive and specific values of ESR and CRP were pointed out by ROC curve analysis (d) at the fourth week after antibiotic treatment

Similar articles

Cited by

References

    1. Hadjipavlou AG, Mader JT, Necessary JT, Muffoletto AJ. Hematogenous pyogenic spinal infections and their surgical management. Spine. 2000;25:1668–1679. doi: 10.1097/00007632-200007010-00010. - DOI - PubMed
    1. Mann S, Schutze M, Sola S, Piek J. Nonspecific pyogenic spondylodiscitis: clinical manifestations, surgical treatment, and outcome in 24 patients. Neurosurg Focus. 2004;17:E3. doi: 10.3171/foc.2004.17.6.3. - DOI - PubMed
    1. Osenbach RK, Zeidman SM. Infections in neurological surgery: diagnosis & management. Philadelphia: Lippincott-Raven; 1999.
    1. Belzunegui J, Intxausti JJ, Dios JR, Del Val N, Rodriguez Valverde V, Gonzalez C, Queiro R, Figueroa M. Haematogenous vertebral osteomyelitis in the elderly. Clin Rheumatol. 2000;19:344–347. doi: 10.1007/PL00011175. - DOI - PubMed
    1. Gasbarrini AL, Bertoldi E, Mazzetti M, Fini L, Terzi S, Gonella F, Mirabile L, Barbanti Brodano G, Furno A, Gasbarrini A, Boriani S. Clinical features, diagnostic and therapeutic approaches to haematogenous vertebral osteomyelitis. Eur Rev Med Pharmacol Sci. 2005;9:53–66. - PubMed

MeSH terms